Back to Search
Start Over
Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians
- Source :
- Annals of Internal Medicine. 173:1002-1003
- Publication Year :
- 2020
- Publisher :
- American College of Physicians, 2020.
-
Abstract
- The prescription drug market in the United States relies on competition to keep prices reasonable. Although many policies have been implemented to spur competition and decrease costs for patients, these policies may be outdated and should be redesigned and updated to achieve success in the current prescription drug market. In this paper, the American College of Physicians (ACP) proposes that new policies should be implemented to prevent market manipulation, help lower-cost alternatives make it to the market faster, and ensure a robust and competitive market for generic and biosimilar drugs. The ACP believes these changes will have a meaningful effect on patients without shifting costs to other areas of the health care system.
- Subjects :
- Prescription Drugs
Prescription drug
Drug Industry
Orphan Drug Production
Market manipulation
01 natural sciences
Competition (economics)
03 medical and health sciences
0302 clinical medicine
Health care
Internal Medicine
Humans
Perfect competition
Medicine
030212 general & internal medicine
0101 mathematics
Biosimilar Pharmaceuticals
Societies, Medical
Economic Competition
Economic competition
Public economics
business.industry
Health Policy
010102 general mathematics
Biosimilar
General Medicine
Organizational Policy
United States
Position paper
business
Subjects
Details
- ISSN :
- 15393704 and 00034819
- Volume :
- 173
- Database :
- OpenAIRE
- Journal :
- Annals of Internal Medicine
- Accession number :
- edsair.doi.dedup.....d95a20b16ae72d1799cdac5372c24563